San Diego CA— Cushman & Wakefield announced that DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, has leased 95,997 square feet of Class A space at the Del Mar Corporate Centre for its new corporate headquarters in Del Mar Heights (San Diego), California. The building will also be the site of the company’s laboratory (the “DermTech Gene Lab”) where DermTech will among other things, process its DermTech Melanoma Test to aid in the early detection of melanoma.
Owned by Kilroy Realty, Del Mar Corporate Centre (DMCC) is a three-building Class A campus in San Diego’s Del Mar Heights neighborhood featuring well-appointed design, beautiful common areas and outdoor lounges, and a prime, prominent presence. DMCC is surrounded by world-class shopping and dining, including Kilroy’s One Paseo and is near many of San Diego’s top neighborhoods. The campus also has excellent visibility and accessibility from Interstate 5.
Cushman & Wakefield’s David Odmark represented DermTech and Cushman & Wakefield’s Brett Ward, Brian Starck and Michael Cassolato represented Kilroy Realty in the transaction.
DermTech’s new headquarters will be located at 12340 El Camino Real, known as Del Mar Corporate Centre II (DMCC II), and will undergo a significant transformation that will include conversion of office space to life science laboratory space.
“We are very excited to welcome and accommodate DermTech in Kilroy’s portfolio. DermTech’s decision to locate its new headquarters in Del Mar Heights is a move that we believe will be the first of many life science companies to cluster in the submarket,” said Brett Ward, Executive Managing Director.
Ward continued, “This transaction also reflects Kilroy’s ability to quickly and successfully convert property in order to meet the needs of today’s life science and biotech companies. A trend we anticipate will continue growing in the area given San Diego’s lack of supply and its position as one of the world’s premier Life Science hubs.”